ICAHN CARL C
Institutional investor · Portfolio as of Q4 2021
Top Holdings16 positions
ICAHN ENTERPRISES LP | 257M | $12.7B | 57.2% | $15.44 | +21.87% | 13 qtrssince 2018-Q4 | Increased 68 |
CHENIERE ENERGY INC | 16.2M | $1.6B | 7.4% | $55.31 | +74.99% | 13 qtrssince 2018-Q4 | Unchanged 0 |
OCCIDENTAL PETROLEUM CORP | 45M | $1.3B | 5.9% | $18.97 | +216.94% | 11 qtrssince 2019-Q2 | Unchanged 0 |
CVR ENERGY INC | 71.2M | $1.2B | 5.4% | $19.52 | -39.01% | 13 qtrssince 2018-Q4 | Unchanged 0 |
BAUSCH HEALTH COS INC | 34.7M | $958.7M | 4.3% | $29.39 | -6.32% | 5 qtrssince 2020-Q4 | Increased 62 |
NEWELL BRANDS INC | 43.7M | $954.5M | 4.3% | $13.04 | +38.03% | 13 qtrssince 2018-Q4 | Unchanged 0 |
FIRSTENERGY CORP | 19M | $788.9M | 3.5% | $28.13 | +23.64% | 4 qtrssince 2021-Q1 | Unchanged 0 |
| 32.1M | $727.1M | 3.3% | — | — | 2 qtrssince 2021-Q3 | Increased 63 | |
HERC HLDGS INC | 4M | $629.8M | 2.8% | $23.61 | +504.28% | 13 qtrssince 2018-Q4 | Decreased 0 |
DANA INC | 14.3M | $326M | 1.5% | $20.31 | -0.50% | 5 qtrssince 2020-Q4 | Unchanged 0 |
WELBILT INC | 11.2M | $265M | 1.2% | — | — | 13 qtrssince 2018-Q4 | Unchanged 0 |
CONDUENT INC | 38.1M | $203.7M | 0.9% | $9.55 | -44.11% | 13 qtrssince 2018-Q4 | Unchanged 0 |
SOUTHWEST GAS HOLDINGS INC | 2.9M | $203.1M | 0.9% | $59.69 | +1.65% | 2 qtrssince 2021-Q3 | Increased 73 |
| 15M | $189.2M | 0.8% | — | — | — | Decreased 0 | |
DELEK US HOLDINGS INC | 7M | $104.7M | 0.5% | $13.28 | -2.94% | 8 qtrssince 2020-Q1 | Decreased 0 |
SANDRIDGE ENERGY INC | 4.8M | $50.4M | 0.2% | $5.53 | +36.35% | 13 qtrssince 2018-Q4 | Unchanged 0 |
ICAHN CARL C manages $22.3B across 16 positions as of Q4 2021. Top holdings: IEP (57.2%), LNG (7.4%), OXY (5.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Exited 1, increased 4, trimmed 3. Top move: SWX (INCREASED, conviction 73). Portfolio: $22.3B across 16 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR